Chelating drugs such as L1 can also be used in other abnormalities of iron metabolism such as in the treatment of the anemia of chronic disease, where L1 appears to redistribute iron from the reticuloendothelial system directly or via transferrin to the erythropoietic tissues for increasing hemoglobin production [122,123]. The gene discussed is TF; the disease is anemia (phenotype).